Drug Screening Market Worth $19.5 billion | MarketsandMarkets

CHICAGO, May 16, 2024 /PRNewswire/ -- Drug Screening Market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a new report by MarketsandMarkets.

Factors such as mounting drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, increasing government funding in major markets, and rising regulatory approvals and service and product launches are the some of the factors driving the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Browse in-depth TOC on "Drug Screening Market"

740 - Tables
62 - Figures
533 - Pages

Drug Screening Market Scope:

Report Coverage	Details
Market Revenue in 2024	$9.1 billion
Estimated Value by 2029	$19.5 billion
Growth Rate	Poised to grow at a CAGR of 16.6%
Market Size Available for	2018–2029
Forecast Period	2024–2029
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product & Service, Sample type, Drug Type, End User, and Region
Geographies Covered	North America (US and Canada), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), Asia Pacific (Japan, China, India, and RoPAC), Latin America (Brazil, Mexico, Rest of Latin America) Middle East & Africa (GCC Countries, Rest of Middle East & Africa)